Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · CONMED (CNMD)

CONMED appoints Celine Martin and Jeff Mirviss to board, expanding it to nine directors

Neutral Impact 2 of 5 leadership Written later

CONMED added two independent directors, Celine Martin and Jeff Mirviss, effective July 1, 2026, and increased the board from eight to nine seats. The company also named Kimberly Lockwood as interim principal accounting officer effective June 1, 2026, and amended its bylaws, effective immediately. Shareholders at the May 18, 2026 annual meeting re-elected or elected seven directors and approved the advisory pay vote.

Key points

  • Celine Martin and Jeff Mirviss join the board effective July 1, 2026; board size rises to nine directors.
  • Kimberly Lockwood becomes Interim Corporate Controller and Interim Principal Accounting Officer effective June 1, 2026.
  • Amended bylaws took effect on Board approval on May 19, 2026; nominations for the 2027 annual meeting must be received between January 18 and February 17, 2027.
  • At the May 18, 2026 annual meeting, the advisory vote on executive compensation passed with 26,230,404 votes for and 1,742,683 against.

The filing

CompanyCONMED (CNMD)
Form8-K, current report
Filed with the SECMay 20, 2026, 8:30 AM ET
Accession number0000816956-26-000057

Items reported: 5.02 Director / Officer Change5.03 Bylaw / Charter Amendment5.07 Shareholder Vote Results

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 20, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.